December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Tempus AI, Inc.

< Previous 1 2 3 4 Next >
News headline image
Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Introduces ‘Preview’: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Reports First Quarter 2026 Results
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus to Host Inaugural Investor Day on May 29, 2026
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus to Report First Quarter 2026 Financial Results on May 5
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Announces Strategic Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Clinical Differentiation Across an ADC Clinical Program
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Reports Fourth Quarter and Full Year 2025 Results
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.